Somatostatin Receptor 5 Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Neurons expressing somatostatin receptor 5 (SSTR5) represent a key population in the hypothalamic and pituitary regulation of hormone secretion, metabolism, and neuronal function. SSTR5 is one of five somatostatin receptor subtypes (SSTR1-5) that mediate the effects of somatostatin (SST), a widely expressed neuropeptide with potent inhibitory effects on hormone release and neuronal excitability.
¶ Gene and Protein
| Property | Value |
|----------|-------|
| Gene Symbol | SSTR5 |
| Chromosomal Location | 16p13.3 |
| Protein Name | Somatostatin receptor 5 |
| UniProt ID | P78540 |
| Protein Class | G protein-coupled receptor (GPCR), Class A |
The SSTR5 gene encodes a 363-amino acid GPCR that couples primarily to Gi/o proteins, inhibiting adenylate cyclase and reducing neuronal excitability.
SSTR5 has the typical seven transmembrane domain structure of GPCRs:
- N-terminal extracellular domain: Ligand binding
- Transmembrane domains (7): TM1-TM7
- Extracellular loops (3): Ligand recognition
- Intracellular loops (3): G protein coupling
- C-terminal tail: Desensitization and internalization
Key features:
- Highest affinity for somatostatin-28 over SST-14
- Distinct binding pocket compared to other SSTRs
- Palmitoylation site in C-terminal tail
SSTR5 is expressed in several brain regions:
- Hypothalamus: Arcuate nucleus, paraventricular nucleus, preoptic area
- Cerebral cortex: Layer 2/3 and layer 5 pyramidal neurons
- Pituitary gland: Anterior and intermediate lobe
- Thalamus: Midline nuclei
- Amygdala: Central and basolateral nuclei
- Hippocampus: CA1-CA3 regions, dentate gyrus
- Brainstem: Dorsal raphe, locus coeruleus
SSTR5 neurons are crucial for hormone control:
- Growth hormone regulation: Inhibits GH secretion from pituitary
- Thyroid function: Modulates TSH release
- Reproductive hormones: Influences LH/FSH
- Prolactin inhibition: Reduces prolactin secretion
¶ Food Intake and Energy Balance
- Anorexigenic signaling: Suppresses appetite
- Energy expenditure: Increases metabolic rate
- Glucose homeostasis: Modulates insulin secretion
- Body weight regulation: Long-term energy balance
- Inhibitory modulation: Reduces neuronal firing
- Synaptic transmission: Modulates excitatory synapses
- Neuroprotection: Anti-excitotoxic effects
- Oscillation regulation: Influences neuronal rhythms
- Learning and memory: Hippocampal SSTR5 in memory
- Mood regulation: Depression and anxiety
- Pain modulation: Analgesic effects of SSTR5
Involvement:
- SSTR5 expression altered in AD brain
- Relationship to somatostatin deficits in AD
- Therapeutic potential of SSTR5 modulation
- Cognitive enhancement strategies
Mechanisms:
- Amyloid-beta interactions
- Cholinergic system modulation
- Neuroprotective signaling
Involvement:
- Altered SSTR5 in basal ganglia
- Motor symptom modulation
- Levodopa-induced dyskinesias
- Non-motor symptoms
Diabetes:
- SSTR5 in pancreatic beta cells
- Insulin secretion modulation
- Therapeutic targeting for diabetes
- Glucose homeostasis
Obesity:
- SSTR5 agonists for weight loss
- Appetite suppression
- Metabolic syndrome treatment
Involvement:
- SSTR5 in pituitary adenomas
- Acromegaly treatment (octreotide, lanreotide)
- Tumor imaging (SSTR scintigraphy)
- Therapeutic targeting
Involvement:
- SSTR5 in mood regulation
- SSRIs affect SSTR5 expression
- Therapeutic potential
- Biomarker potential
SSTR5 activates multiple intracellular cascades:
- Gi/o protein signaling: Inhibition of adenylate cyclase
- MAPK pathway: ERK1/2 activation
- PLC pathway: Modulation of calcium
- PI3K/Akt: Cell survival signaling
- SSTR1-SSTR4: Can form heterodimers
- Dopamine receptors: Cross-talk in pituitary
- Ghrelin receptor: Metabolic interactions
-
SSTR5 agonists:
- Octreotide, lanreotide (approved)
- Pasireotide (SSTR5-selective)
- New generations in development
-
SSTR5 antagonists:
- Potential for cognitive enhancement
- Depression applications
-
Multireceptor ligands:
- Pan-somatostatin analogs
- SSTR2/5 selective compounds
- Acromegaly: First-line treatment
- Neuroendocrine tumors: Therapeutic targeting
- Cushing's disease: Pituitary-directed therapy
- Cognitive disorders: SSTR5 modulators
- SSTR5 expression as tumor marker
- Imaging with radiolabeled somatostatin analogs
- Circuit mapping: Defining SSTR5 neuron populations
- Optogenetics: Manipulating SSTR5 circuits
- Single-cell transcriptomics: SSTR5 neuron heterogeneity
- Drug discovery: Brain-penetrant SSTR5 modulators
The study of Somatostatin Receptor 5 Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.